Demant
Health Care Equipment
Denmark
ESRS disclosure: S4-4_17
Tags Tree
Selected: 0
No matching results found.
- Does the undertaking disclose the process for setting targets related to managing material negative impacts, advancing positive impacts, and managing material risks and opportunities, including whether and how it engaged directly with consumers and/or end-users, their legitimate representatives, or credible proxies with insight into their situation? Additionally, does the undertaking disclose whether any initiatives or processes aimed at delivering positive impacts for consumers and/or end-users are also designed to support the achievement of one or more of the UN Sustainable Development Goals, such as through commitments like advancing UN SDG 3 to ensure healthy lives and promote well-being for all at all ages?
-
Question Id: S4-4_17
In 2024, Demant established new targets for advancing positive impacts on people with hearing loss: improving more than 16 million lives by 2030 and increasing awareness by performing hearing tests on more than 2 million people by 2030. The target-setting process involved internal experts and was approved by Demant’s Executive Leadership Team and endorsed by the Board of Directors. Consumers and end-users were not directly involved in the process.
Report Date: 4Q2024Relevance: 65%